In Alzheimer's disease, tau undergoes a biochemical change called phosphorylation and can be measured as Phosphorylated tau-181, causing the protein to break away from the neurons and form ...

A new review was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science), on October 29, 2024, Volume 16, Issue 20, titled, "Brain aging and Alzheimer's ...

Alzheimer’s affects over 50 million people globally, but non-human primates rarely exhibit the toxic protein deposits central ...

Alzheimer's disease—the most common form of dementia—is a progressive neurological disorder that causes brain cells to ...

Alzheimer's disease, the leading cause of dementia, affects over 55 million people worldwide. The disease is characterized by the buildup of amyloid-beta plaques and tau protein tangles in the brain, ...

SignalChem Biotech provides diverse recombinant Tau proteins for research, helping advance tau-targeted therapies that may ...

Researchers discover protective pathway against Alzheimer's in mice Alzheimer's disease is marked by the gradual degeneration ...

A groundbreaking medication designed to delay the onset of Alzheimer's has received approval for use within the EU. The drug, ...

Lecanemab is the first treatment for Alzheimer’s disease licensed for use in Great Britain that shows some evidence of ...